Barclays PLC Greenwich Life Sciences, Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 10,582 shares of GLSI stock, worth $97,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,582
Previous 10,582
-0.0%
Holding current value
$97,671
Previous $96,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GLSI
# of Institutions
49Shares Held
1.24MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$2.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA269KShares$2.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA139KShares$1.28 Million0.0% of portfolio
-
Credit Agricole S A87KShares$803,0100.0% of portfolio
-
Northern Trust Corp Chicago, IL82.8KShares$764,0500.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $119M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...